£12.0M
The financing was co-led by Illumina Ventures and Mérieux Equity Partners to support the development and commercialisation of the company gene editing safety technology.
Broken String Biosciences
Genomics company building a platform to drive the development of safer cell and gene therapies.
£12.0MTotal raised
Broken String Biosciences is a genomics company building a proprietary platform to map DNA breaks and enhance the safety of cell and gene therapies. Headquartered in Cambridge, the firm works to accelerate the clinical development of gene editing programmes.
Categories
Team
FD
Felix Dobbs
Chief Executive Officer